Navigation Links
Scientist Discovers Crucial Part of Blood-Clotting Process

A researcher at The University of Texas Health Center at Tyler has discovered how a small but crucial part of the blood-clotting process works. Once the process// is thoroughly understood, synthetic chemicals can be designed to regulate it, thus preventing excessive bleeding or blood clotting. The findings of Pierre Neuenschwander, Ph.D., and his team are published in the Aug. 11, 2006, edition of the Journal of Biological Chemistry.

Dr. Neuenschwander, an associate professor of biochemistry, and his team are investigating one step in the blood-clotting process that involves factor IXa, an enzyme (IX and the other factors are read as Roman numerals). Enzymes are proteins that change the rate of chemical reactions without needing an external energy source, such as heat.

“If you don’t have factor IXa, you have hemophilia, or excessive bleeding, and your blood doesn’t clot properly. So you have to have factor IXa, but not too much of it. If it’s left unregulated, you get clots where you don’t want them and end up with strokes and heart attacks,” Dr. Neuenschwander said.

“It’s been difficult to study how factor IXa works. It’s not usually a very active enzyme. This research paper is one of the first to show that a physiologically relevant molecule, heparin, can modulate the activity of factor IXa,” he said. Heparin is a naturally occurring mixture of compounds that prevents unwanted blood clotting. It is a molecule with many places where enzymes and other substances can bind to activate or stop biochemical reactions in the cell.

By revealing how factor IXa works, it should be possible to make synthetic chemicals that prevent strokes and heart attacks, Dr. Neuenschwander said. Conversely, you could make synthetic activators that could stop the unwanted bleeding that occurs in hemophilia, he added.

Dr. Neuenschwander has been investigating factor IXa for the past six years. His first research was funded by a smal l grant from the American Heart Association. Currently, his research is funded by a five-year, $1.375 million grant from the National Institutes of Health that ends in 2010. The NIH grant originally was for just four years; the NIH thought enough of Dr. Neuenschwander’s research to award him another year of funding.

He and his team plan to spend the next year experimenting with antithrombin, a small naturally occurring molecule that inactivates several enzymes involved in the coagulation process. They hope to gain understanding of another step in that process.

“We want to see if we can design inhibitors that would mimic what heparin does. Our goal is to develop these and eventually test them in clinical trials,” Dr. Neuenschwander said.

(Source Newswise)
'"/>




Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. Scientists found ancient Human Germ Killer
3. Scientists locate key hormone involved in appetite control
4. Scientists open the book of life
5. Scientists review SARS
6. Scientists crack dengue fever puzzle
7. Scientists push to lower hidden sodium in food
8. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
9. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
10. Scientists reveal the secrets of sarcasm
11. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... "FCPX editors ... customizable inside of Final Cut Pro X," said Christina Austin - CEO of Pixel ... style. Final Cut Pro X users can now reveal the media of ...
(Date:6/26/2016)... ... 27, 2016 , ... Quality metrics are proliferating in cancer care, and are ... the eye of the beholder, according to experts who offered insights and commentary in ... Managed Care. For the full issue, click here . , For the American ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... ANDOVER, Mass. and SAN CLEMENTE, Calif. ... California -based mobile pulmonary function testing company, is now ... portable PFT devices developed by ndd Medical Technologies , Inc. ... PFT testing done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ... CA , can get any needed testing done in the ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... Ill. , June 23, 2016  In a startling report ... are failing their residents by lacking a comprehensive, proven plan to ... a definitive ranking of how states are tackling the worst ... to only four states – Kentucky , ... Vermont . Of the 28 failing states, three ...
Breaking Medicine Technology: